MoneyWorks4Me

Zenotech Laboratorie - Quaterly Results

28 Oct 2022 Evaluate
The sales for the September 2022 quarter moved up 28.95% to Rs. 102.90 millions as compared to Rs. 79.80 millions during the corresponding quarter last year.The company almost doubled its revenue to Rs. 27.66 millions  from Rs. 9.47 millions in the quarter ended September 2022.OP of the company witnessed a marginal growth to 56.55 millions from 30.85 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 102.90 79.80 28.95 226.56 178.71 26.78 365.65 224.45 62.91
Other Income 6.47 0.30 2056.67 6.95 1.00 595.00 6.29 4.08 54.17
PBIDT 56.55 30.85 83.31 127.92 87.69 45.88 180.90 67.89 166.46
Interest 0.00 3.34 0.00 1.12 7.98 -85.96 12.15 15.48 -21.51
PBDT 56.55 27.51 105.56 126.80 79.71 59.08 168.75 52.41 221.98
Depreciation 18.05 18.04 0.06 35.91 35.28 1.79 69.74 64.56 8.02
PBT 38.50 9.47 306.55 90.89 44.43 104.57 99.01 -12.15 -914.90
TAX 10.84 0.00 0.00 25.52 0.00 0.00 -122.75 0.00 0.00
Deferred Tax 10.84 0.00 0.00 25.52 0.00 0.00 -122.75 0.00 0.00
PAT 27.66 9.47 192.08 65.37 44.43 47.13 221.76 -12.15 -1925.19
Equity 610.31 610.31 0.00 610.31 610.31 0.00 610.31 610.31 0.00
PBIDTM(%) 54.96 38.66 42.16 56.46 49.07 15.07 49.47 30.25 63.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..